Authorities have seized more than 12,000 doses of illegal weight-loss injections from a suspected black-market drug factory operating out of a £2.2 million Georgian country house in Northamptonshire. The raid occurred on May 28 at Moulton Grange as part of an ongoing investigation into unlicensed medicines.
Moulton Grange, a property boasting 28 acres of landscaped grounds, is known for hosting luxury weddings and corporate events. Online reviews describe it as a "perfect venue" and "simply magical."
Investigators from the Medicines and Healthcare products Regulatory Agency (MHRA) suspect the venue was used as a "large-scale facility to manufacture, assemble, and distribute unlicensed weight loss medicines, including retatrutide and tirzepatide, as well as peptide products." Tirzepatide is the active ingredient in the drug Mounjaro, while retatrutide is an experimental treatment still in clinical trials.
The MHRA characterized the raid as the UK's largest seizure of unlicensed weight-loss injections and stated that the operation targeted an "organised criminal group."
Officers arrested two 29-year-old men in connection with the raid, who were later released. The BBC identified Moulton Grange as the raid location, though the MHRA did not initially name the property.
Moulton Grange is a Grade II-listed building constructed in the late 18th and early 19th centuries. It features a grand Georgian facade, a ballroom, and 12 bedrooms. The property was last sold for £2.2 million in 2017.
The property is owned by Faiz Hameed, 61, and Rashda Hameed, 59, who are directors of Moulton Grange Limited, a property management company. In 2014, Faiz Hameed was fined £312,000 by Northampton Magistrates' Court for failing to meet housing standards in properties he owned.
This is the second MHRA operation in Northamptonshire in recent months linked to the alleged production of illegal weight-loss injections. A previous raid in October 2025 resulted in the seizure of fewer unlicensed drugs.
Investigators noted that this operation was the first time they had uncovered a facility producing drugs marketed under its own brand, identified as 'Alluvi'.
Andy Morling, head of the MHRA's Criminal Enforcement Unit, stated that the packaging found at the manor house appeared "sophisticated" and "authentic-looking." He added that the MHRA's regulation exists to protect the public and that dismantling this facility would prevent significant harm.
Moulton Grange Limited was contacted for comment.